As of the latest SEC filings, Semnur Pharmaceuticals, Inc. (SMNR) is held by 2 institutional funds. The largest fund shareholder is Calamos Market Neutral Income Fund (CVSCX), holding an estimated $8,855.00 in market value, representing a significant portion of its portfolio.